Associated Papers
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo.
Giannakopoulou E et al.
Nature Cancer, 2023
37783807 (PubMed )
Supplement: 43018_2023_642_MOESM1_ESM.pdf
Select a paper to view details